• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例因依维莫司治疗转移性肾细胞癌引发的危及生命的间质性肺炎致死病例:关于日本人群间质性肺病风险增加的评论

A Fatal Case of Life-Threatening Interstitial Pneumonitis Induced by Everolimus for Metastatic Renal Cell Carcinoma: A Comment about the Increased Risk of Interstitial Lung Disease in Japanese.

作者信息

Murakami Yasukiyo, Fujita Tetsuo, Wakatabe Yoji, Iwamura Masatsugu

机构信息

Department of Urology, Kitasato University School of Medicine, Japan.

出版信息

Case Rep Urol. 2019 Jan 31;2019:2703871. doi: 10.1155/2019/2703871. eCollection 2019.

DOI:10.1155/2019/2703871
PMID:30838154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6374873/
Abstract

We describe an 81-year-old woman with metastatic renal cell carcinoma who did not recover from life-threatening interstitial pneumonitis induced by everolimus therapy. She received everolimus due to disease progression after sunitinib, but 2 months after starting everolimus treatment, she visited the emergency department after developing a sudden fever and dyspnea. Chest CT revealed diffuse ground-glass opacities, thickening of the interlobular septa, and consolidation throughout both lung fields. The diagnosis was surmised to be everolimus-induced interstitial pneumonitis. Everolimus administration was stopped and 3 courses of steroid pulse therapy were administered, along with intensive care, but the patient died due to rapid respiratory failure.

摘要

我们描述了一名81岁的转移性肾细胞癌女性患者,她未能从依维莫司治疗引发的危及生命的间质性肺炎中康复。她在舒尼替尼治疗后疾病进展,因此接受了依维莫司治疗,但在开始依维莫司治疗2个月后,她在出现突发发热和呼吸困难后前往急诊科就诊。胸部CT显示双肺野弥漫性磨玻璃影、小叶间隔增厚及实变。推测诊断为依维莫司诱发的间质性肺炎。停用依维莫司,并给予3个疗程的糖皮质激素冲击治疗及重症监护,但患者因快速呼吸衰竭死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0422/6374873/f07cd1cd82a7/CRIU2019-2703871.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0422/6374873/77dd9290e269/CRIU2019-2703871.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0422/6374873/f07cd1cd82a7/CRIU2019-2703871.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0422/6374873/77dd9290e269/CRIU2019-2703871.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0422/6374873/f07cd1cd82a7/CRIU2019-2703871.002.jpg

相似文献

1
A Fatal Case of Life-Threatening Interstitial Pneumonitis Induced by Everolimus for Metastatic Renal Cell Carcinoma: A Comment about the Increased Risk of Interstitial Lung Disease in Japanese.一例因依维莫司治疗转移性肾细胞癌引发的危及生命的间质性肺炎致死病例:关于日本人群间质性肺病风险增加的评论
Case Rep Urol. 2019 Jan 31;2019:2703871. doi: 10.1155/2019/2703871. eCollection 2019.
2
A case of pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma.一例与依维莫司治疗肾细胞癌相关的肺囊虫肺炎。
Jpn J Clin Oncol. 2013 May;43(5):559-62. doi: 10.1093/jjco/hyt019. Epub 2013 Feb 18.
3
Patterns of interstitial lung disease during everolimus treatment in patients with metastatic renal cell carcinoma.在转移性肾细胞癌患者中使用依维莫司治疗时的间质性肺病模式。
Jpn J Clin Oncol. 2012 May;42(5):442-6. doi: 10.1093/jjco/hys033. Epub 2012 Mar 20.
4
[A case of interstitial lung disease due to sunitinib].[一例因舒尼替尼导致的间质性肺病]
Hinyokika Kiyo. 2012 Sep;58(9):481-5.
5
Two cases of everolimus-associated interstitial pneumonia in patients with renal cell carcinoma.
Intern Med. 2011;50(24):3013-7. doi: 10.2169/internalmedicine.50.6133. Epub 2011 Dec 15.
6
Drug-induced pneumonitis: thin-section CT findings in 60 patients.药物性肺炎:60例患者的薄层CT表现
Radiology. 2002 Sep;224(3):852-60. doi: 10.1148/radiol.2243011236.
7
[A case of pneumonitis caused by Seisin-renshi-in, herbal medicine].[一例由中药细辛仁志饮引起的肺炎病例]
Nihon Kokyuki Gakkai Zasshi. 2008 Jan;46(1):31-4.
8
[A case of drug-induced interstitial pneumonitis in rheumatoid arthritis treated with bucillamine].[一例用青霉胺治疗类风湿关节炎时发生药物性间质性肺炎的病例]
Nihon Kokyuki Gakkai Zasshi. 2001 Jan;39(1):55-9.
9
[Immune-related pneumonitis caused by programmed death-1 inhibitor Pembrolizumab: a case report and literature review].程序性死亡-1抑制剂帕博利珠单抗引起的免疫相关性肺炎:一例报告及文献综述
Zhonghua Jie He He Hu Xi Za Zhi. 2017 Oct 12;40(10):736-743. doi: 10.3760/cma.j.issn.1001-0939.2017.10.006.
10
Characterization of pneumonitis in patients with advanced non-small cell lung cancer treated with everolimus (RAD001).评估晚期非小细胞肺癌患者接受依维莫司(RAD001)治疗后的间质性肺病。
J Thorac Oncol. 2009 Nov;4(11):1357-63. doi: 10.1097/JTO.0b013e3181ba20b1.

本文引用的文献

1
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.肾癌,2017 年第 2 版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2017 Jun;15(6):804-834. doi: 10.6004/jnccn.2017.0100.
2
A prospective observational study on the evaluation of everolimus-related adverse events in metastatic renal cell carcinoma after first-line anti-vascular endothelial growth factor therapy: the AFINITE study in France.一项关于一线抗血管内皮生长因子治疗后转移性肾细胞癌中依维莫司相关不良事件评估的前瞻性观察性研究:法国的AFINITE研究。
Support Care Cancer. 2017 Jul;25(7):2055-2062. doi: 10.1007/s00520-017-3594-y. Epub 2017 Feb 10.
3
mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm.
mTOR 抑制剂所致癌症患者的间质性肺病:全面综述及实用管理算法。
Int J Cancer. 2016 May 15;138(10):2312-21. doi: 10.1002/ijc.29887. Epub 2015 Oct 27.
4
Interstitial lung disease during targeted therapy in metastatic renal cell carcinoma: a case series from three centres.转移性肾细胞癌靶向治疗期间的间质性肺疾病:来自三个中心的病例系列
Med Oncol. 2014 Sep;31(9):147. doi: 10.1007/s12032-014-0147-9. Epub 2014 Aug 15.
5
Interstitial lung disease associated with gefitinib in Japanese patients with EGFR-mutated non-small-cell lung cancer: combined analysis of two Phase III trials (NEJ 002 and WJTOG 3405).表皮生长因子受体突变型非小细胞肺癌患者接受吉非替尼治疗相关的间质性肺疾病:两项 III 期临床试验(NEJ002 和 WJTOG3405)的联合分析。
Jpn J Clin Oncol. 2013 Jun;43(6):664-8. doi: 10.1093/jjco/hyt049. Epub 2013 Apr 12.
6
[Management of side effects of everolimus treatment for metastatic renal cell carcinoma].[依维莫司治疗转移性肾细胞癌的副作用管理]
Hinyokika Kiyo. 2012 Nov;58(11):647-50.
7
Drug induced interstitial lung disease.药物性间质性肺疾病
Open Respir Med J. 2012;6:63-74. doi: 10.2174/1874306401206010063. Epub 2012 Jul 27.
8
Postmarketing surveillance study of erlotinib in Japanese patients with non-small-cell lung cancer (NSCLC): an interim analysis of 3488 patients (POLARSTAR).厄洛替尼在日本非小细胞肺癌(NSCLC)患者中的上市后监测研究:3488 例患者的中期分析(POLARSTAR)。
J Thorac Oncol. 2012 Aug;7(8):1296-303. doi: 10.1097/JTO.0b013e3182598abb.
9
Patterns of interstitial lung disease during everolimus treatment in patients with metastatic renal cell carcinoma.在转移性肾细胞癌患者中使用依维莫司治疗时的间质性肺病模式。
Jpn J Clin Oncol. 2012 May;42(5):442-6. doi: 10.1093/jjco/hys033. Epub 2012 Mar 20.
10
Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma.与依维莫司用于晚期肾细胞癌患者相关的不良反应的管理。
Eur J Cancer. 2011 Jun;47(9):1287-98. doi: 10.1016/j.ejca.2011.02.014. Epub 2011 Apr 8.